DEFA14A: BlackRock Health Sciences Term Trust Faces Proxy Fight from Saba Capital

Activist hedge fund Saba Capital Management is attempting to replace BlackRock as the investment advisor for the BlackRock Health Sciences Term Trust (BMEZ), prompting BlackRock to urge shareholders to vote using the WHITE proxy card to retain the current board and investment management agreement.

Summary

• BlackRock is urging shareholders of the BlackRock Health Sciences Term Trust (BMEZ) to vote against a proposal by Saba Capital Management to terminate BlackRock as the investment advisor.
• Saba is attempting to install its own board members.
• BlackRock argues that Saba's motives are self-serving and could harm shareholders by leading to loss of income, higher fees, riskier investments, poor performance, and potential liquidation of the fund.
• The current board unanimously recommends voting FOR the BlackRock nominees and AGAINST Saba's proposal.
• BlackRock highlights BMEZ's 14% return on market price year-to-date in 2024, outperforming 93% of all closed-end funds.
• BMEZ has bought back over $95 million of shares since inception, adding ~$18 million in value.
• In 2032, shareholders will have an opportunity to receive 100% liquidity at net asset value via fund liquidation or tender offer.

Sentiment

Score: 4

Explanation: The document conveys a defensive tone due to the ongoing proxy fight. While highlighting positive performance metrics, the overall sentiment is weighed down by the potential negative impacts of the activist investor's involvement.

Positives

• BMEZ has delivered a 14% return on market price year-to-date in 2024, outperforming 93% of all closed-end funds.
• The fund has a discount management program involving share repurchases.
• BMEZ has bought back over $95 million of shares, adding ~$18 million in value since inception.
• Shareholders will have an opportunity to receive 100% liquidity at net asset value via fund liquidation or tender offer in 2032.

Negatives

• Saba Capital Management is attempting to replace BlackRock as the investment advisor, creating uncertainty.
• BlackRock warns that Saba's actions could lead to loss of income, higher fees, riskier investments, and potential liquidation of the fund at 'fire sale prices'.
• The fund is subject to market fluctuations, as indicated by the statement that 'market price and NAV will fluctuate with market conditions'.

Risks

• The proxy fight with Saba Capital Management introduces uncertainty and potential disruption to the fund's management.
• BlackRock warns of potential risks associated with Saba's involvement, including loss of income, higher fees, riskier investments, and poor performance.
• The fund's performance is subject to market conditions, which can lead to fluctuations in market price and NAV.

Future Outlook

BlackRock is focused on defending the fund against Saba's proposals and maintaining the current investment strategy. In 2032, all shareholders will have an opportunity to receive 100% liquidity at net asset value via fund liquidation or tender offer.

Management Comments

• BlackRock believes that Saba's motives conflict with shareholders' best interests.
• The Board unanimously recommends voting FOR the Boards Nominees.
• The Board unanimously recommends voting AGAINST Sabas proposal to terminate the investment management agreement with BlackRock.

Industry Context

This proxy fight highlights the increasing activism in the closed-end fund space, where hedge funds often seek to unlock value by influencing fund management or strategy. Saba Capital is a known activist investor in this sector.

Comparison to Industry Standards

• The document states that BMEZ's 14% return on market price year-to-date in 2024, outperforming 93% of all closed-end funds. This suggests that BMEZ is performing well compared to its peers.
• Without specific competitor data, it's difficult to provide a detailed comparison, but the outperformance claim indicates a strong relative position.

Stakeholder Impact

• Shareholders are directly impacted by the proxy fight and the potential changes to the fund's management and investment strategy.
• BlackRock's reputation and management of the fund are at stake.
• The outcome of the vote will determine the future direction and performance of the fund, affecting shareholder returns.

Next Steps

• Shareholders are urged to vote using the WHITE proxy card.
• The Annual Meeting will be held on June 25th.
• Shareholders are encouraged to contact Georgeson LLC with any questions.

Key Dates

Keywords

BlackRock, Saba Capital, BMEZ, proxy fight, investment advisor, closed-end fund, shareholder, proxy, board nominees, investment management agreement, health sciences